FDA CSV Guidance & 21 CFR Part 11 Alignment

FDA Computer System Validation: What the Latest Guidance Means for You

November 15, 2025November 14, 2025 digi

FDA Computer System Validation: What the Latest Guidance Means for You Comprehensive Guide to FDA Computer System Validation and Its Regulatory Implications Understanding FDA computer system validation is critical for pharmaceutical and life sciences organizations operating under U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), Medicines and Healthcare products Regulatory Agency (MHRA), and…

FDA Computer System Validation Guidance: Translating Principles Into a Practical CSV Plan

November 15, 2025November 14, 2025 digi

FDA Computer System Validation Guidance: Translating Principles Into a Practical CSV Plan Implementing FDA Computer System Validation Guidance: A Step-by-Step Practical CSV Plan Computer system validation (CSV) is a cornerstone of regulatory compliance within the pharmaceutical industry, especially under the oversight of the U.S. Food and Drug Administration (FDA). The FDA computer system validation guidance…

FDA CSV Guidance & 21 CFR Part 11 Alignment

FDA Computer Validation: How to Defend Your Approach During Inspection

November 15, 2025November 14, 2025 digi

FDA Computer Validation: How to Defend Your Approach During Inspection Defending Your FDA Computer Validation Approach During Regulatory Inspections Effective FDA computer validation is a critical component of regulatory compliance in pharmaceutical manufacturing and related regulated sectors. During an FDA inspection, auditors will scrutinize your computer system validation (CSV) approach, including risk assessments, documentation, test…

FDA CSV Guidance & 21 CFR Part 11 Alignment

FDA CSV Guidance: Risk-Based Computer System Validation in Practice

November 15, 2025November 14, 2025 digi

FDA CSV Guidance: Risk-Based Computer System Validation in Practice Implementing Risk-Based Computer System Validation Per FDA CSV Guidance Effective computer system validation (CSV) is a cornerstone of ensuring data integrity, product quality, and compliance within the pharmaceutical industry. The FDA CSV guidance emphasizes a risk-based approach tailored to focus validation efforts on features that most…

FDA CSV Guidance & 21 CFR Part 11 Alignment

21 CFR Part 11 Computer System Validation: Electronic Records and Signatures

November 15, 2025November 14, 2025 digi

21 CFR Part 11 Computer System Validation: Electronic Records and Signatures Comprehensive Guide to 21 CFR Part 11 Computer System Validation for Electronic Records and Signatures In the current pharmaceutical manufacturing and regulatory environment, compliance with 21 CFR Part 11 computer system validation is imperative to ensure the integrity, security, and reliability of electronic records…

FDA CSV Guidance & 21 CFR Part 11 Alignment

21 CFR Part 11 Data Integrity: Audit Trails, Access and Electronic Records

November 15, 2025November 14, 2025 digi

21 CFR Part 11 Data Integrity: Audit Trails, Access and Electronic Records – Comprehensive Guide Ensuring 21 CFR Part 11 Data Integrity through Audit Trails, Access Controls, and Electronic Records For pharmaceutical and regulatory professionals working within the US, UK, EU, and global markets, compliance with 21 CFR Part 11 data integrity requirements remains a…

FDA CSV Guidance & 21 CFR Part 11 Alignment

GMP 21 CFR Part 11: Building a Compliance Roadmap for GxP Systems

November 15, 2025November 14, 2025 digi

GMP 21 CFR Part 11: Building a Compliance Roadmap for GxP Systems Step-by-Step Guide to Achieving GMP 21 CFR Part 11 Compliance for GxP Computerized Systems GMP 21 CFR Part 11 sets the benchmark for compliance and integrity in electronic records and signatures within regulated pharmaceutical environments. For GxP computerized systems—encompassing manufacturing, quality control, and…

FDA CSV Guidance & 21 CFR Part 11 Alignment

GMP CFR 21 Part 11: Gap Assessments and Remediation Plans

November 15, 2025November 14, 2025 digi

GMP CFR 21 Part 11: Gap Assessments and Remediation Plans Step-by-Step Guide to GMP CFR 21 Part 11 Gap Assessments and Remediation Planning In pharmaceutical manufacturing and quality environments, compliance with GMP CFR 21 Part 11 remains a critical requirement. Part 11, focusing on electronic records and electronic signatures, sets the regulatory foundation for computerized…

FDA CSV Guidance & 21 CFR Part 11 Alignment

FDA System Validation: Aligning Vendor Documentation With FDA Expectations

November 15, 2025November 14, 2025 digi

FDA System Validation: Aligning Vendor Documentation With FDA Expectations Comprehensive Guide to FDA System Validation and Vendor Documentation Alignment In the pharmaceutical and biotechnology industries, FDA system validation is a critical compliance activity ensuring that computerized systems function as intended within regulatory frameworks such as 21 CFR Part 11 and GxP principles. Leveraging vendor documentation…

FDA CSV Guidance & 21 CFR Part 11 Alignment

Data Integrity and Compliance With Drug cGMP: Making CSV Part of Your Strategy

November 15, 2025November 14, 2025 digi

Ensuring Data Integrity and Compliance With Drug cGMP Through Effective Computer System Validation Step-by-Step Guide to Achieving Data Integrity and Compliance With Drug cGMP via Computer System Validation In the pharmaceutical industry, maintaining data integrity and compliance with drug cGMP is critical for product quality, patient safety, and regulatory approval. Computerized systems, widely used to…

FDA CSV Guidance & 21 CFR Part 11 Alignment